体外膜肺氧合治疗出血并发症概述
Summary of Complications in Extracorporeal Membrane Oxygenation Therapy for Bleeding
DOI: 10.12677/ACM.2023.13112572, PDF,    科研立项经费支持
作者: 古丽亚尔·艾合买提：新疆医科大学第一临床医学院，新疆 乌鲁木齐；宋云林：新疆医科大学第一附属医院重症医学二科，新疆 乌鲁木齐
关键词: 体外膜肺氧合；出血；抗凝；Extracorporeal Membrane Oxygenation； Bleeding； Anticoagulation
摘要: 出血是体外膜肺氧合治疗很常见的并发症，如何尽早发现和如何处理并预防一直是临床工作中的难点。目前抗凝监测策略及抗凝目标范围仍无统一意见。深入探讨凝血相关指标与体外膜肺氧合治疗出血风险之间的关系可帮助指导临床决策，减少出血相关并发症的发生，改善患者的预后。
Abstract: Hemorrhage is a common complication of extracorporeal membrane oxygenation therapy, and how to detect and manage and prevent it as soon as possible has always been a challenge in clinical work. At present, there is still no consensus on the anticoagulation monitoring strategy and the scope of anticoagulation targets. Deeply exploring the relationship between coagulation related indicators and the risk of bleeding in extracorporeal membrane oxygenation therapy can help guide clinical decision-making, reduce the occurrence of bleeding related complications, and improve patient prognosis.
文章引用：古丽亚尔·艾合买提, 宋云林. 体外膜肺氧合治疗出血并发症概述[J]. 临床医学进展, 2023, 13(11): 18320-18325. https://doi.org/10.12677/ACM.2023.13112572

参考文献

[1] Maratta, C., Potera, R.M., van Leeuwen, G., et al. (2020) Extracorporeal Life Support Organization (ELSO): 2020 Pedi-atric Respiratory ELSO Guideline. ASAIO Journal, 66, 975-979. [Google Scholar] [CrossRef] 
[2] Esper, S.A., Welsby, I.J., Subramaniam, K., et al. (2017) Adult Extracorporeal Membrane Oxygenation: An International Survey of Transfusion and Anticoagulation Techniques. Vox Sanguinis, 112, 443-452. [Google Scholar] [CrossRef] [PubMed]
[3] Willers, A., Swol, J., Kowalewski, M., et al. (2021) Extracorporeal Life Support in Hemorrhagic Conditions: A Systematic Review. ASAIO Journal, 67, 476-484. [Google Scholar] [CrossRef] 
[4] Premraj, L., Brown, A., Burrell, A., et al. (2022) Hyperoxia during Venoarterial ECMO: Culprit or Co-Variate? A Comment from the BLENDER Investigators. Critical Care, 26, Article Number: 345. [Google Scholar] [CrossRef] [PubMed]
[5] Tauber, H., Ott, H., Streif, W., et al. (2015) Extracorporeal Membrane Oxygenation Induces Short-Term Loss of High-Molecular-Weight von Willebrand Factor Multimers. Anes-thesia & Analgesia, 120, 730-736. [Google Scholar] [CrossRef] 
[6] Massaro, A.N., Jeromin, A., Kadom, N., et al. (2013) Se-rum Biomarkers of MRI Brain Injury in Neonatal Hypoxic Ischemic Encephalopathy Treated with Whole-Body Hypo-thermia: A Pilot Study. Pediatric Critical Care Medicine, 14, 310-317. [Google Scholar] [CrossRef] 
[7] Mazzeffi, M., Greenwood, J., Tanaka, K., et al. (2016) Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemo-stasis. The Annals of Thoracic Surgery, 101, 682-689. [Google Scholar] [CrossRef] [PubMed]
[8] Hoffman, K.R., Burrell, A.J.C., Diehl, A., et al. (2021) Ele-vated Carboxyhaemoglobin as a Novel Indicator for Extracorporeal Membrane Haemolysis and Oxygenator Exchange. Critical Care, 25, Article Number: 159. [Google Scholar] [CrossRef] [PubMed]
[9] 丁格, 姚杨, 李思雨, 等. 凝血相关指标与体外膜肺氧合治疗出血风险的研究进展[J]. 中国临床实用医学, 2022, 13(4): 74-77. [Google Scholar] [CrossRef] 
[10] Nougier, C., Benoit, R. and Dargaud, Y. (2020) Response to “Studies on Hemostasis in COVID-19 Deserve Careful Reporting of the Laboratory Methods, Their Signif-icance and Their Limitation”: Don’t Throw the Baby out with the Bathwater. Journal of Thrombosis and Haemostasis, 18, 3128-3130. [Google Scholar] [CrossRef] [PubMed]
[11] Honore, P.M., Redant, S., Djimafo, P., et al. (2022) Differ-ence of 11 Years between Two Periods of VV-ECMO Does Not Impact Mortality in Large Centres: We Are Not Sure. Critical Care, 26, Article Number: 149. [Google Scholar] [CrossRef] [PubMed]
[12] Weingart, C., Lubnow, M., Philipp, A., et al. (2015) Comparison of Coagulation Parameters, Anticoagulation, and Need for Transfusion in Patients on Interventional Lung Assist or Veno-Venous Extracorporeal Membrane Oxygenation: Comparison of Patients on iLA and VV-ECMO. Artificial Or-gans, 39, 765-773. [Google Scholar] [CrossRef] [PubMed]
[13] Ang, A.L., Teo, D., Lim, C.H., et al. (2009) Blood Transfusion Requirements and Independent Predictors of Increased Transfusion Requirements among Adult Patients on Extracorporeal Membrane Oxygenation: A Single Centre Experience. Vox Sanguinis, 96, 34-43. [Google Scholar] [CrossRef] [PubMed]
[14] Buscher, H., Vukomanovic, A., Benzimra, M., et al. (2017) Blood and Anticoagulation Management in Extracorporeal Membrane Oxygenation for Surgical and Nonsurgical Patients: A Single-Center Retrospective Review. Journal of Cardiothoracic and Vascular Anesthesia, 31, 869-875. [Google Scholar] [CrossRef] [PubMed]
[15] Mazzeffi, M.A., Tanaka, K., Roberts, A., et al. (2019) Bleeding, Thrombosis, and Transfusion with Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients. Journal of Cardiothoracic and Vascular Anesthesia, 33, 1216-1220. [Google Scholar] [CrossRef] [PubMed]
[16] Burstein, B., Wieruszewski, P.M., Zhao, Y.-J., et al. (2019) Anti-coagulation with Direct Thrombin Inhibitors during Extracorporeal Membrane Oxygenation. World Journal of Critical Care Medicine, 8, 87-98. [Google Scholar] [CrossRef] [PubMed]
[17] Uricchio, M.N., Ramanan, R., Esper, S.A., et al. (2022) Bivalirudin VERSUS Unfractionated Heparin in Patients with Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation. ASAIO Journal.
https://www.x-mol.com/paper/1514114466089852928?adv
[18] Li, D., Sun, M., Zhang, J., et al. (2022) Is Bi-valirudin an Alternative Anticoagulant for Extracorporeal Membrane Oxygenation (ECMO) Patients? A Systematic Re-view and Meta-Analysis. Thrombosis Research, 210, 53-62. [Google Scholar] [CrossRef] [PubMed]

为你推荐